XML 57 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of fair value and notional amounts of derivative contracts by major product type on a gross basis
The following tables identify the fair value and notional amounts of derivative contracts by major product type on a gross basis for the Company and the Consolidated Funds as of June 30, 2017 and December 31, 2016:  
 
 
As of June 30, 2017
 
As of December 31, 2016
 
 
Assets 
 
Liabilities 
 
Assets 
 
Liabilities 
The Company
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
Foreign exchange contracts
 
$
32,616

 
$
384

 
$
84,564

 
$
3,737

 
$
62,830

 
$
3,171

 
$

 
$

Total derivatives, at fair value(2)
 
$
32,616

 
$
384

 
$
84,564

 
$
3,737

 
$
62,830

 
$
3,171

 
$

 
$

 
 
As of June 30, 2017
 
As of December 31, 2016
 
 
Assets
 
Liabilities
 
Assets 
 
Liabilities 
Consolidated Funds 
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
 
Notional(1)
 
Fair Value
Foreign exchange contracts
 
$

 
$

 
$

 
$

 
$
25,304

 
$
529

 
$

 
$

Other financial instruments
 
8,011

 
2,809

 

 

 
3,575

 
291

 
(204
)
 
(2,999
)
Total derivatives, at fair value(3)
 
8,011


2,809






28,879


820


(204
)

(2,999
)
Other—equity(4)
 

 

 

 

 
253

 
24

 

 

Total
 
$
8,011


$
2,809


$


$


$
29,132


$
844


$
(204
)

$
(2,999
)
 
(1)
Represents the total contractual amount of derivative assets and liabilities outstanding.
(2)
As of June 30, 2017, the Company had the right to, but elected not to, offset $0.4 million of its derivative assets and liabilities. As of December 31, 2016, the Company did not have any derivative liabilities to offset its derivative assets.
(3)
As of June 30, 2017 and December 31, 2016, the Consolidated Funds offset $0.1 million and $1.4 million of their derivative assets and liabilities, respectively.
(4)
Includes the fair value of warrants which are presented as equity securities within investments of the Consolidated Funds in the Condensed Consolidated Statements of Financial Condition.